Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Serine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (D)-Serine SCHEMBL31186649 | 1.00 | — | — | |
| Serine SCHEMBL28890911 | 1.00 | — | — | |
| Serine SCHEMBL10623299 | 1.00 | — | — | |
| Serine SCHEMBL28890910 | 1.00 | — | — | |
| (D)-Serine SCHEMBL43094 | 0.97 | — | — | |
| Serine SCHEMBL1332181 | 0.97 | — | — | |
| Serine SCHEMBL2023739 | 0.97 | SLC1A1 (0.59) | — | |
| (D)-Serine SCHEMBL6660617 | 0.97 | SLC1A1 (0.59) | — | |
| Serine SCHEMBL6929773 | 0.97 | SLC1A1 (0.59) | — | |
| Serine SCHEMBL2023740 | 0.97 | SLC1A1 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1343808-A2 | PROCESS FOR THE SYNTHESIS OF A PEPTIDE HAVING A TRP RESIDUE | Kinerton Limited (IE) | 2003-09-17 | — | — | EP | claimed |
| WO-2002051861-A2 | PROCESS FOR THE SYNTHESIS OF A PEPTIDE HAVING A TRYPTOPHAN RESIDUE | KINERTON LIMITED (IE) | 2002-07-04 | — | — | WO | claimed |
| JP-57035549-A | — | — | None | — | — | JP | disclosed |
| JP-57032256-A | — | — | None | — | — | JP | disclosed |
| JP-57035548-A | — | — | None | — | — | JP | disclosed |
| CN-119707944-A | Hydrated compound and preparation method thereof | 福建省闽东力捷迅药业股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| EP-3293522-A2 | LIPIDOMIC BIOMARKERS FOR IDENTIFICATION OF HIGH-RISK CORONARY ARTERY DISEASE PATIENTS | Zora Biosciences OY (FI) | 2018-03-14 | — | — | EP | disclosed |
| EP-2385374-B2 | Lipidomic biomarkers for atherosclerosis and cardiovascular disease | ZORA BIOSCIENCES OY (FI) | 2018-02-28 | — | — | EP | disclosed |
| US-20160025751-A1 | Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients | ZORA BIOSCIENCES OY (FI) | 2016-01-28 | — | — | US | disclosed |
| WO-2013012846-A1 | PROCESS FOR PREPARING PHOSPHORYLATED AMINO ACIDS | CEPHALON, INC. (US) | 2013-01-24 | — | — | WO | disclosed |
| WO-2013012416-A1 | PROCESS FOR PREPARING PHOSPHORYLATED AMINO ACIDS | CEPHALON, INC. (US) | 2013-01-24 | — | — | WO | disclosed |
| EP-2385374-A1 | Lipidomic biomarkers for atherosclerosis and cardiovascular disease | Zora Biosciences OY (FI) | 2011-11-09 | — | — | EP | disclosed |
| US-8040688-B2 | Circuit board unit and electronic device | FUJITSU LIMITED (JP) | 2011-10-18 | — | — | US | disclosed |
| US-4725645-A | USING A TRIALKYLCYANOSILANE | SOLVAY & CIE. (SOCIETE ANONYME) (BE) | 1988-02-16 | — | — | US | disclosed |
| EP-0164389-B1 | PREPARATION OF PHENYL ALANINES BY HYDROGENATION OF PHENYL SERINES | ALKALOIDA VEGYéSZETI GYáR (HU) | 1987-04-01 | — | — | EP | disclosed |
| EP-0164389-A1 | PREPARATION OF PHENYL ALANINES BY HYDROGENATION OF PHENYL SERINES. | ALKALOIDA VEGYESZETI GYAR (HU) | 1985-12-18 | — | — | EP | disclosed |
| WO-1985002609-A1 | PREPARATION OF PHENYL ALANINES BY HYDROGENATION OF PHENYL SERINES | ALKALOIDA VEGYÉSZETI GYÁR (HU) | 1985-06-20 | — | — | WO | disclosed |
| JP-S5735549-A | OBTAINING METHOD OF AMINO ACID HYDRATE CRYSTAL | AJINOMOTO CO INC | 1982-02-26 | — | — | JP | disclosed |
| JP-S5735548-A | DRYING METHOD OF AMINO ACID CRYSTAL | AJINOMOTO CO INC | 1982-02-26 | — | — | JP | disclosed |
| JP-S5732256-A | CRYSTALLIZATION OF SERINE | AJINOMOTO CO INC | 1982-02-20 | — | — | JP | disclosed |